Literature DB >> 2894876

Relaxing actions of procaterol, a beta 2-adrenoceptor stimulant, on smooth muscle cells of the dog trachea.

T Fujiwara1, K Sumimoto, T Itoh, H Suzuki, H Kuriyama.   

Abstract

1. The effects of procaterol, a beta 2-adrenoceptor agonist, on smooth muscle cells of the dog trachea were investigated by use of microelectrode and isometric tension recording methods, and by measurement of Ca transients as estimated from the fura-2 fluorescence, adenosine 3':5'-cyclic monophosphate (cyclic AMP) and breakdown of phosphatidylinositols. 2. Procaterol hyperpolarized the membrane and increased the ionic conductance (above 10 nM) in a dose-dependent manner. These actions were inhibited by propranolol. 3. Procaterol inhibited the mechanical responses evoked by acetylcholine (ACh), histamine or 5-hydroxytryptamine (5-HT), in the presence or absence of Ca2+ in the bath solution, but not that evoked by high concentrations of ACh (1 microM). The ID50 value of procaterol for the peak amplitude of the ACh-induced contraction (30 nM) was 0.3 nM. The equivalent values for the histamine-induced phasic and tonic responses (10 microM) were 0.15 and 0.01 nM), respectively. 4. Procaterol (over 1 nM) increased the amount of cyclic AMP in a dose-dependent manner which was blocked by prior application of propranolol. 5. Procaterol did not alter the changes in the amounts of phosphatidylinositol 4,5-bisphosphate (PI-P2) and phosphatidic acid (PA) induced by ACh, histamine or 5-HT. Thus, the synthesis of inositol 1,4,5-trisphosphate is not affected by stimulation of the beta 2-adrenoceptor. 6. ACh increased the free Ca2+ concentration to a greater extent than that produced by histamine or 5-HT. These changes were reduced by procaterol, except for those induced by high concentrations of ACh (over 1 microM). 7. It is concluded that procaterol relaxes tissues precontracted by various agonists due to a reduction in the free Ca2+. This inhibitory action may be due to an increase in the amount of cyclic AMP but does not result from an inhibition of the hydrolysis of phosphatidyl inositols. The hyperpolarization induced by procaterol may partly contribute to the observed relaxation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894876      PMCID: PMC1853760          DOI: 10.1111/j.1476-5381.1988.tb11422.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Pharmacological studies of OPC-2009, a newly synthesized selective beta adrenoceptor stimulant, in the broncho-motor and cardiovascular system of the anesthetized dog.

Authors:  Y Yabuuchi; S Yamashita; S S Tei
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

2.  Actions of procaterol (OPC-2009), a new beta2-adrenoceptor stimulant, on pulmonary resistance, contractions of the soleus muscle, and cardiovascular system of the anaesthetized cat.

Authors:  S Yamashita; M Takai; Y Yabuuchi
Journal:  J Pharm Pharmacol       Date:  1978-05       Impact factor: 3.765

3.  Effects of full and partial beta-adrenergic agonists and antagonists on human lung adenylate cyclase.

Authors:  M Delhaye; G Taton; J C Camus; P Chatelain; P Robberecht; M Waelbroeck; J Christophe
Journal:  Biochem Pharmacol       Date:  1983-06-15       Impact factor: 5.858

4.  Inhibition of smooth muscle tension by cyclic AMP-dependent protein kinase.

Authors:  W G Kerrick; P E Hoar
Journal:  Nature       Date:  1981-07-16       Impact factor: 49.962

Review 5.  Factors modifying contraction-relaxation cycle in vascular smooth muscles.

Authors:  H Kuriyama; Y Ito; H Suzuki; K Kitamura; T Itoh
Journal:  Am J Physiol       Date:  1982-11

6.  Phosphorylation by cyclic adenosine 3':5'-monophosphate-dependent protein kinase regulates myosin light chain kinase.

Authors:  M A Conti; R S Adelstein
Journal:  Fed Proc       Date:  1980-04

7.  Alterations in blood levels of carbohydrate and lipid metabolites and of cyclic AMP mediated by beta1- and beta2-adrenoceptors in beagle dogs: effects of procaterol, a new selective beta2-adrenoceptor agonist.

Authors:  Y Irie; T Igawa; T Hosokawa; Y Saitoh
Journal:  Eur J Pharmacol       Date:  1979-02-01       Impact factor: 4.432

8.  New selective beta2-adrenoreceptor stimulants 5(1-hydroxy-2-isopropylaminobutyl)- and 5-(1-hydroxy-2-ethylaminobutyl)-8-hydroxycarbostyril hydrochlorides (OPC-2009 and OPC-2030) and cyclic AMP concentration.

Authors:  I Takayanagi; N Kondo; H Yamashita; T Hongo; K Takagi
Journal:  J Pharm Pharmacol       Date:  1977-03       Impact factor: 3.765

9.  Does activation of cyclic AMP dependent phosphorylation induced by beta-adrenergic agent control the tone of vascular muscle?

Authors:  M Hirata; H Kuriyama
Journal:  J Physiol       Date:  1980-10       Impact factor: 5.182

10.  Excitation--contraction coupling in smooth muscle cells of the guinea-pig mesenteric artery.

Authors:  T Itoh; H Kuriyama; H Suzuki
Journal:  J Physiol       Date:  1981-12       Impact factor: 5.182

View more
  10 in total

1.  Beta-adrenoceptor stimulation inhibits histamine-stimulated inositol phospholipid hydrolysis in bovine tracheal smooth muscle.

Authors:  I P Hall; S J Hill
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

2.  Pre- and post-junctional actions of procaterol, a beta 2-adrenoceptor stimulant, on dog tracheal tissue.

Authors:  Y Ito
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

3.  Differences between the effects of cromakalim and nifedipine on agonist-induced responses in rabbit aorta.

Authors:  K M Bray; A H Weston; S Duty; D T Newgreen; J Longmore; G Edwards; T J Brown
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

4.  Signalling pathway for histamine activation of non-selective cation channels in equine tracheal myocytes.

Authors:  Y X Wang; M I Kotlikoff
Journal:  J Physiol       Date:  2000-02-15       Impact factor: 5.182

5.  Inhibition of histamine-stimulated inositol phospholipid hydrolysis by agents which increase cyclic AMP levels in bovine tracheal smooth muscle.

Authors:  I P Hall; J Donaldson; S J Hill
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

6.  Beta-adrenoceptor subtypes and the opening of plasmalemmal K(+)-channels in trachealis muscle: electrophysiological and mechanical studies in guinea-pig tissue.

Authors:  S J Cook; R C Small; J L Berry; P Chiu; S J Downing; R W Foster
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  Tolerance to cromakalim in the rat uterus in vivo.

Authors:  S J Downing; M Miller; M Hollingsworth
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

8.  Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells.

Authors:  I P Hall; S Widdop; P Townsend; K Daykin
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

Review 9.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Beta-adrenergic agonists regulate KCa channels in airway smooth muscle by cAMP-dependent and -independent mechanisms.

Authors:  H Kume; I P Hall; R J Washabau; K Takagi; M I Kotlikoff
Journal:  J Clin Invest       Date:  1994-01       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.